Cargando…

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

BACKGROUND: Epithelial-mesenchymal transition (EMT) is involved in important malignant features of cancer cells, like invasion, metastatic potential, anti-apoptotic and stem-cell like phenotypes. Among several transcription factors, SNAI2/SLUG is supposed to play an essential role for EMT. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atmaca, Akin, Wirtz, Ralph W, Werner, Dominique, Steinmetz, Kristina, Claas, Silke, Brueckl, Wolfgang M, Jäger, Elke, Al-Batran, Salah-Eddin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404179/ https://www.ncbi.nlm.nih.gov/pubmed/25928859 http://dx.doi.org/10.1186/s12885-015-1310-1

Ejemplares similares

The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer
por: Atmaca, Akin, et al.
Publicado: (2012)

Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma
por: Werner, Dominique, et al.
Publicado: (2013)

SNAI2/Slug promotes growth and invasion in human gliomas
por: Yang, Hong Wei, et al.
Publicado: (2010)

Transcriptomal profiling of the cellular response to DNA damage mediated by Slug (Snai2)
por: Pérez-Caro, M, et al.
Publicado: (2008)

Corrigendum to: The transcription factors slug (SNAI2) and snail (SNAI1) regulate phospholipase D (PLD) promoter in opposite ways towards cancer cell invasion
Publicado: (2023)

Correction: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas
por: von Minckwitz, Gunter, et al.
Publicado: (2006)

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas
por: von Minckwitz, Gunter, et al.
Publicado: (2005)

SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24- Phenotype
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2010)

The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing
por: Werner, Dominique, et al.
Publicado: (2014)

SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression
por: Esposito, Silvia, et al.
Publicado: (2015)

The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
por: Fenouille, Nina, et al.
Publicado: (2012)

Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)
por: Brueckl, Natalie F., et al.
Publicado: (2021)

Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2
por: Chimge, Nyam-Osor, et al.
Publicado: (2011)

Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC)
por: Amilca-Seba, Katyana, et al.
Publicado: (2022)

Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer
por: Goetze, Thorsten Oliver, et al.
Publicado: (2022)

IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)
por: Zirkel, Anne, et al.
Publicado: (2013)

Wnt/CTNNB1 Signal Transduction Pathway Inhibits the Expression of ZFP36 in Squamous Cell Carcinoma, by Inducing Transcriptional Repressors SNAI1, SLUG and TWIST
por: Zanfi, Emma D., et al.
Publicado: (2020)

SLUG Manual - SLUG Interface to GEANT
por: DeWolf, R S
Publicado: (1993)

Deletion of Snai2 and Snai3 Results in Impaired Physical Development Compounded by Lymphocyte Deficiency
por: Pioli, Peter D., et al.
Publicado: (2013)

SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition
por: Sundararajan, Vignesh, et al.
Publicado: (2019)

SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell Stage and Become Segregated to the TE in the Mouse Blastocyst
por: Bell, Christine E., et al.
Publicado: (2009)

Absence of a Major Role for the Snai1 and Snai3 Genes in Regulating Skeletal Muscle Regeneration in Mice
por: Norton, Christine R., et al.
Publicado: (2013)

VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
por: Thomaidis, Thomas, et al.
Publicado: (2014)

Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis
por: Qureshi, Rehana, et al.
Publicado: (2022)

Multimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective
por: Goetze, Thorsten Oliver, et al.
Publicado: (2019)

Not All Slugs Are the Same: Variation in Growth and Development of the Slug Deroceras reticulatum
por: Shirley, Mark, et al.
Publicado: (2020)

Recolonization by Slugs: Vertical and Horizontal Dispersal by the Field Slug, Deroceras reticulatum
por: Port, Gordon, et al.
Publicado: (2021)

Pancreatic cancer SLUGged
por: Josselsohn, Rachel H., et al.
Publicado: (2020)

Experimental Study on the Slugging Characteristics of Gas–Liquid Slug Flow in Horizontal Pipes
por: Wu, Xiao, et al.
Publicado: (2022)

Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review
por: Chiorean, Elena Gabriela, et al.
Publicado: (2019)

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma
por: Lordick, Florian, et al.
Publicado: (2021)

The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression, and associates with good prognosis in breast cancer
por: Mendoza-Villanueva, Daniel, et al.
Publicado: (2016)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

FTO Inhibits Epithelial Ovarian Cancer Progression by Destabilising SNAI1 mRNA through IGF2BP2
por: Sun, Meige, et al.
Publicado: (2022)

Listening to Slugs: Acceptability and Consumption of Molluscicide Pellets by the Grey Field Slug, Deroceras reticulatum
por: de Silva, Samantha Mirhaya, et al.
Publicado: (2021)

Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression
por: Liu, Bo-Wen, et al.
Publicado: (2019)

The Snail Family Gene Snai3 Is Not Essential for Embryogenesis in Mice
por: Bradley, Cara K., et al.
Publicado: (2013)

Zebrafish snai2 mutants fail to phenocopy morphant phenotypes
por: Bickers, Cara, et al.
Publicado: (2018)

Prognostic values of SNAI family members in breast cancer patients
por: Li, Deheng, et al.
Publicado: (2020)

Analysis of the Effect of SNAI Family in Breast Cancer and Immune Cell
por: Tu, Yifei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vj3r045emkeq0tsn2nicus6glp